Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin’s lymphoma
Lin Yang, Qiuling Zhao, Ting Chen, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3767-3780
Closed Access | Times Cited: 9

Showing 9 citing articles:

Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress
Hui Chen, Xiangna Guan, Chi He, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 237-250
Closed Access | Times Cited: 8
Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors
Cheng-Hu Xie, Bo Liu, Zilan Song, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16201-16221
Closed Access | Times Cited: 11
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
Ioanna Ε. Stergiou, C. Tsironis, Stavros P. Papadakos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2369-2369
Open Access | Times Cited: 4
Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors
Xiaorong Qiu, Rong Liu, Huan Ling, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116310-116310
Closed Access | Times Cited: 4
Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation
M. Ahn, Eun Hye Kim, Yunha Choi, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0305261-e0305261
Open Access | Times Cited: 3
Progress in characterizing ABC multidrug transporters in zebrafish
Joanna R. Thomas, William J.E. Frye, Robert W. Robey, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101035-101035
Closed Access | Times Cited: 5
Unraveling the NLRP Family: Structure, Function, Activation, Critical Influence on Tumor Progression, and Potential as Targets for Cancer Therapy
Xueqing Zhou, Yongguang Tao, Yongyong Shi
Cancer Letters (2024), pp. 217283-217283
Closed Access | Times Cited: 1
Application of PD-1/PD-L1 Inhibitors in Gynecological Tumors
学维 陈
World Journal of Cancer Research (2024) Vol. 14, Iss. 01, pp. 48-54
Closed Access
Opportunities and challenges for targeting HPK1 in cancer immunotherapy
Jiamei Xu, Ying‐Zhou Li, Xinyi Chen, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107866-107866
Closed Access
Page 1

Scroll to top